• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

michelle.giles@unimelb.edu.au

Credentials


Position
Clinician Scientist Vaccine Research Leader
Department of Infectious Diseases
ORCID

0000-0003-3007-1822

Prof Michelle Giles

Clinician Scientist Vaccine Research Leader
Department of Infectious Diseases

196 Scholarly works
9 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies
    DOI: 10.1016/j.vaccine.2026.128399
  • 2026

    Journal article

    Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals.
    DOI: 10.18773/austprescr.2026.011
  • 2026

    Journal article

    Preventing infections in immunosuppressed patients
    DOI: 10.18773/austprescr.2026.003
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Promoat: An Adaptive Platform Trial of Antibiotic Therapy to Improve Outcomes From Preterm Prelabour Rupture of Membranes
  • 2024

    Research Contracts

    Phase 3 Study of the Safety and Immunogenicity of a COVID-19 and Influenza Combination Vaccine and a Standalone Nanoparticle Influenza Vaccine
  • 2024

    Research contracts (non-grants)

    A Phase 3, Multicenter, Observer-Blind, Randomized, Controlled Study to Evaluate the Immunogenicity, Reactogenicity, and Safety of a Self-Amplifying RNA COVID-19 Vaccine (ARCT-2303), Administered Concomitantly With Quadrivalent Influenza Vaccines, in Adul
  • 2020

    Journal article

    COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission
    DOI: 10.1111/ajo.13204
Michelle Giles

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022–2024)
    DOI: 10.1016/j.vaccine.2025.128041
  • 2025

    Journal article

    Follow-up and Outcomes of Infants Perinatally-exposed to HIV in a Low-prevalence Setting: The Multicenter Children's HIV Exposure Study 2
    DOI: 10.1093/jpids/piaf109
  • 2025

    Journal article

    Inequity in Fertility Treatment for Patients that Speak a Language Other than English: A Retrospective Cohort Study
    DOI: 10.1007/s40615-024-02188-6
  • 2025

    Journal article

    Systematic review and meta-analysis of interventions to increase the uptake of vaccines recommended during pregnancy
    DOI: 10.1038/s41541-025-01120-1
  • 2025

    Journal article

    Pharmacokinetics of Sofosbuvir and Velpatasvir for Hepatitis C Treatment in Pregnancy
    DOI: 10.3390/biomedicines13102462
  • 2025

    Journal article

    The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence
    DOI: 10.1016/j.vaccine.2025.127659
  • 2025

    Journal article

    Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study
    DOI: 10.1016/j.eclinm.2025.103428

RECENT PROJECTS

  • 2025

    Research contracts (non-grants)

    POPSICLE Study Analysis

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224